# Concentration and Activity of Lapatinib in Vestibular Schwannomas

> **NCT00863122** · EARLY_PHASE1 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 26 (actual)

## Conditions studied

- Vestibular Schwannoma
- NF2
- Neurofibromatosis 2
- Acoustic Neuroma
- Auditory Tumor

## Interventions

- **DRUG:** lapatinib

## Key facts

- **NCT ID:** NCT00863122
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2021-01-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00863122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00863122, "Concentration and Activity of Lapatinib in Vestibular Schwannomas". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00863122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*